サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用整形外科薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）
市場調査レポート
商品コード
1408979

動物用整形外科薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）

Global Veterinary Orthopedic Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 222 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
動物用整形外科薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）
出版日: 2024年01月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用整形外科薬の市場規模は、2022年に38億8,000万米ドルに達し、2023～2030年の予測期間中にCAGR 9.11%で成長し、2030年には77億9,000万米ドルに達すると予測されています

動物用整形外科薬とは、動物の筋骨格系の状態や傷害の診断、治療、予防に焦点を当てた専門的な獣医学です。この獣医学分野は、様々な動物種の骨、関節、靭帯、腱、筋肉に関する問題を扱います。

市場力学

動物用整形外科薬市場は、いくつかの重要な要因によって成長を遂げています。コンパニオンアニマルの幸福に対する認識と関心の高まりは、ペットの飼い主が筋骨格系の状態に対する高度な治療を求めるようになり、専門的な動物用整形外科薬に対する需要の高まりに寄与しています。変形性関節症や十字靭帯損傷など、動物の整形外科的問題の有病率は増加傾向にあり、これは動物の高齢化や活動量の増加といった要因に後押しされています。整形外科用インプラントや低侵襲手術の技術革新により治療成績が向上しており、獣医医療技術や手術手技の進歩は極めて重要な役割を果たしています。獣医学界や研究機関との協力関係は、知識の交換や新しい治療法の開発に貢献しています。ペット保険業界の成長はさらに市場に影響を与え、飼い主が高度な整形外科治療を受けやすくなっています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、動物用整形外科薬の世界市場における各セグメントを包括的に評価することもできます。動物用整形外科薬産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける動物用整形外科薬市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場ハイライト
  • 世界市場スナップショット

第3章 動物用整形外科薬 - 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 動物用整形外科薬の世界市場分析：製品別

  • 概要：製品別
  • 実績データと予測データ
  • 分析：製品別
  • 生物製剤
  • ビスコサプリメント
  • 医薬品

第6章 動物用整形外科薬の世界市場分析：動物別

  • 概要：動物別
  • 実績データと予測データ
  • 分析：動物別
  • イヌ
  • ネコ
  • 馬
  • 牛
  • 豚
  • その他

第7章 動物用整形外科薬の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 変形性関節症
  • 退行性関節疾患
  • 関節の炎症/痛み
  • その他

第8章 動物用整形外科薬の世界市場分析：投与経路別

  • 概要：投与経路別
  • 実績データと予測データ
  • 分析：投与経路別
  • 経口
  • 非経口
  • 局所

第9章 動物用整形外科薬の世界市場分析：最終用途別

  • 概要：最終用途別
  • 実績データと予測データ
  • 分析：最終用途別
  • 動物病院
  • 動物クリニック
  • その他

第10章 動物用整形外科薬の世界市場分析：地域別

  • 展望：地域別
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 動物用整形外科薬企業の競合情勢

  • 動物用整形外科薬市場の競合
  • 提携／協力／協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Elanco Animal Health
  • American Regent Inc.
  • Merck Animal Health（Merck & Co. Inc）
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Virbac
  • Biogenesis Bago
  • Ardent Animal Health LLC
  • Bioiberica S.A.U
  • PetVivo Holdings Inc.（Spryng）
  • Contipro A.S.
  • VetStem Inc.
  • Enso Discoveries
  • Contura Vet US
  • T-Cyte Therepeutics
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Product (USD MN)
  • Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Market Sales by Geography (USD MN)
  • Viscosupplements Market Sales by Geography (USD MN)
  • Pharmaceuticals (Steroids, NSAIDS, Others) Market Sales by Geography (USD MN)
  • Analysis Market by Animal (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Equine Market Sales by Geography (USD MN)
  • Cattle Market Sales by Geography (USD MN)
  • Swine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Osteoarthritis Market Sales by Geography (USD MN)
  • Degenerative Joint Disease Market Sales by Geography (USD MN)
  • Joint Inflammation/Pain Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral (Intra-muscular, Intra-articular, Others) Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Veterinary Hospitals Market Sales by Geography (USD MN)
  • Veterinary Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Veterinary Orthopedic Medicine Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Veterinary Orthopedic Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Veterinary Orthopedic Medicine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Animal
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Market Sales by Geography (USD MN)
  • Viscosupplements Market Sales by Geography (USD MN)
  • Pharmaceuticals (Steroids, NSAIDS, Others) Market Sales by Geography (USD MN)
  • Global Market Analysis by Animal (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Equine Market Sales by Geography (USD MN)
  • Cattle Market Sales by Geography (USD MN)
  • Swine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Osteoarthritis Market Sales by Geography (USD MN)
  • Degenerative Joint Disease Market Sales by Geography (USD MN)
  • Joint Inflammation/Pain Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral (Intra-muscular, Intra-articular, Others) Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Veterinary Hospitals Market Sales by Geography (USD MN)
  • Veterinary Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113276

The global demand for Veterinary Orthopedic Medicine Market is presumed to reach the market size of nearly USD 7.79 BN by 2030 from USD 3.88 BN in 2022 with a CAGR of 9.11% under the study period 2023 - 2030.

Veterinary orthopedic medicine refers to the specialized veterinary medicine that focuses on the diagnosis, treatment, and prevention of musculoskeletal conditions and injuries in animals. This branch of veterinary medicine addresses issues related to bones, joints, ligaments, tendons, and muscles in various animal species.

MARKET DYNAMICS

The Veterinary orthopedic medicine market is experiencing growth driven by several key factors. Increased awareness and concern for the well-being of companion animals contribute to a rising demand for specialized veterinary orthopedic care as pet owners seek advanced treatments for musculoskeletal conditions. The prevalence of orthopedic issues in animals, including osteoarthritis and cruciate ligament injuries, is on the rise, fueled by factors like aging animal populations and increased engagement in activities. Advancements in veterinary medical technology and surgical techniques play a pivotal role, with innovations in orthopedic implants and minimally invasive procedures enhancing treatment outcomes. Collaborations within the veterinary community and with research institutions contribute to knowledge exchange and the development of new treatment modalities. The growing pet insurance industry further impacts the market, facilitating access to advanced orthopedic treatments for pet owners.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary orthopedic medicine. The growth and trends of veterinary orthopedic medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the veterinary orthopedic medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Biologics (Stem Cells, Platelet-Rich Plasma (Prp), Monoclonal Antibody)
  • Viscosupplements
  • Pharmaceuticals (Steroids, Nsaids, Others)

By Animal

  • Canine
  • Feline
  • Equine
  • Cattle
  • Swine
  • Others

By Application

  • Osteoarthritis
  • Degenerative Joint Disease
  • Joint Inflammation/Pain
  • Other

By Route Of Administration

  • Oral
  • Parenteral (Intra-Muscular, Intra-Articular, Others)
  • Topical

By End-Use

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Orthopedic Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Orthopedic Medicine market include Zoetis, Inc., Boehringer Ingelheim, Elanco Animal Health, American Regent, Inc., Merck Animal Health (Merck & Co. Inc), Vetoquinol S.A., Ceva Sante Animale, Virbac, Biogenesis Bago, Ardent Animal Health, LLC, Bioiberica S.A.U, PetVivo Holdings, Inc. (Spryng), Contipro A.S., VetStem, Inc., Enso Discoveries, Contura Vet US, T-Cyte Therepeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . VETERINARY ORTHOPEDIC MEDICINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Animal
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Route of Administration
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Historic and Forecast Sales by Regions
  • 5.5 Viscosupplements Historic and Forecast Sales by Regions
  • 5.6 Pharmaceuticals (Steroids, NSAIDS, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY ANIMAL

  • 6.1 Overview by Animal
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Animal
  • 6.4 Canine Historic and Forecast Sales by Regions
  • 6.5 Feline Historic and Forecast Sales by Regions
  • 6.6 Equine Historic and Forecast Sales by Regions
  • 6.7 Cattle Historic and Forecast Sales by Regions
  • 6.8 Swine Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Osteoarthritis Historic and Forecast Sales by Regions
  • 7.5 Degenerative Joint Disease Historic and Forecast Sales by Regions
  • 7.6 Joint Inflammation/Pain Historic and Forecast Sales by Regions
  • 7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1 Overview by Route of Administration
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Route of Administration
  • 8.4 Oral Historic and Forecast Sales by Regions
  • 8.5 Parenteral (Intra-muscular, Intra-articular, Others) Historic and Forecast Sales by Regions
  • 8.6 Topical Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY END-USE

  • 9.1 Overview by End-use
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-use
  • 9.4 Veterinary Hospitals Historic and Forecast Sales by Regions
  • 9.5 Veterinary Clinics Historic and Forecast Sales by Regions
  • 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE VETERINARY ORTHOPEDIC MEDICINE COMPANIES

  • 11.1. Veterinary Orthopedic Medicine Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF VETERINARY ORTHOPEDIC MEDICINE INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Zoetis Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Elanco Animal Health
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. American Regent Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Merck Animal Health (Merck & Co. Inc)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Vetoquinol S.A.
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Ceva Sante Animale
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Virbac
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Biogenesis Bago
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Ardent Animal Health LLC
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Bioiberica S.A.U
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. PetVivo Holdings Inc. (Spryng)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Contipro A.S.
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. VetStem Inc.
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Enso Discoveries
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Contura Vet US
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. T-Cyte Therepeutics
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies